• 한국응용과학기술학회지
• /
• 제40권6호
• /
• pp.1309-1321
• /
• 2023

본 연구는 8주간의 고강도 동계 훈련 시 L-아르기닌 섭취가 남자 대학 태권도 겨루기 선수의 경기수행능력, 젖산, 젖산탈수소효소 및 암모니아에 미치는 영향을 구명하기 위해 L-아르기닌 섭취군(n=14), 위약군(n=14)으로 구분하여 실시하였다. L-아르기닌 섭취군은 일일 아침 1 g, 점심 1 g, 저녁 1 g으로 총 3 g 섭취하였고 위약군은 말토덱스트린을 동일한 방법으로 섭취하였다. 8주간의 동계 훈련 프로그램은 70-90%HRR로 실시하였다. 측정된 자료의 L-아르기닌 섭취군과 위약군 간의 그룹 및 시기 간 상호작용 효과는 two-way repeated measures ANOVA, 그룹 내 시기 간 차이는 paired t-test를 사용하였으며, 그룹 간 차이는 independent t-test를 사용하여 분석하였다. 그 결과 TAAA (Taekwondo-specific aerobic anaerobic agility) test를 통한 경기수행능력 중 평균 발차기 수에서 그룹×시기 간 상호작용 효과가 나타났으며 그룹 간 주효과가 나타났다(p<.05). 또한, 발차기 피로지수에서 그룹×시기 간 상호작용 효과가 나타났다(p<.05). 한편, 젖산에서는 시기 간 주효과가 나타났으며(p<.05) 젖산탈수소효소에서 상호작용 효과 및 시기 간 주효과 나타났다(p<.05). 암모니아의 경우 그룹×시기 간 상호작용 효과가 나타났다(p<.05). 이러한 결과는 남자 대학 태권도 겨루기 선수의 고강도 훈련 후 피로에 쉽게 노출되는 선수들에게 L-아르기닌 섭취로 인해 체내 피로 유발 물질들을 신속하게 제거하는 데 긍정적인 역할을 할 수 있다고 사료된다. 따라서 고강도 엘리트 태권도 겨루기 운동선수의 경기수행능력 향상과 피로 회복 방법으로 L-아르기닌 섭취를 권장한다.

• 한국식품영양학회지
• /
• 제1권2호
• /
• pp.102-107
• /
• 1988

Production of calcium lactate very useful for medical supplies of Ca-therapy was obtained by lactic acid fermentation of lactobacillus sporogenes, a spore forming lactic acid bacterium. Corn steep liquor 1%, soybean enzyme hydrolysate 3%, yeast extract powder 2% can substitute for yeast extract and peptone as nutrient sort traces in fermentation medium using 10% glucose concentration. In the calcium lactate production medium containing yeast extract powder 2%, glucose 18%, CaCO3 12%, the lactic acid fermentation was carried out at 45$^{\circ}C$ for 4days with continuous agitation of 100 rpm. As results, fermentation yield was 97.5%. The five steps such as protein coagulation, decolorizing evaporating, crystallizing, and drying were carried out to harvest calcium lactate from 10l of supernatant of fermented medium to be removed cell and CaCO3. As results, 2065.0g of white crystal calcium lactate dihyrate was recovered and a yield of 84.9% was obtained.

• 한국식품저장유통학회:학술대회논문집
• /
• 한국식품저장유통학회 2003년도 춘계총회 및 제22차 학술발표회
• /
• pp.136-136
• /
• 2003

Calcium lactate has been known extending shelf-life of several lactic acid fermented foods through buffer action with lactic acid and binding of calcium and pectic polysaccharides in the tissue. But, the effects in kimchi during storage and distribution has not been observed. Calcium lactate is tasteless, nontoxic compounds commonly used in a number of food products. Recent observations have indicated the potential usefulness of calcium lactate as food additive which has anticariogenic-, antimicrobial-, anticalculus, anti- carcinogenic effects and enhancement of bone mineral density. In this work we determined the effects of calcium lactate(CaL)-treatment(0, 1, 2 and 3% against salted Chinese cabbage) on the pH, acidity, microbial counts, content of alcohol insoluble substance and calcium texture, color, scanning electron microscopic observation of kimchi tissue and sensory test during storage. pH of CaL treated kimchi were higher(3.78∼3.92) than that of control products(3.58). Total microbe(TM) of CaL treated kimchis were lower but ratio of lactic acid bacteria against TM was higher than those of control products, respectively. Calcium content of treated products were 3-5 times higher than control products. The hardness and crispy taste of treated products were remarkably higher than those of control products evaluated by SEM observation AIS analysis, sensory and textural analysis. Moreover, evaluation on the pH, acidity and sensory test showed the shelf-life of treated kimchi(CaL 2%) to be 25-30 days, which was 13-15 days longer than that of control products.

• Journal of Chest Surgery
• /
• 제55권2호
• /
• pp.143-150
• /
• 2022

Background: The effectiveness of extracorporeal membrane oxygenation (ECMO) for patients with refractory cardiogenic shock or cardiac arrest is being established, and serum lactate is well known as a biomarker of end-organ perfusion. We evaluated the efficacy of pre-ECMO lactate for predicting 6-month survival in patients with acute coronary syndrome (ACS) undergoing ECMO. Methods: We reviewed the medical records of 148 patients who underwent veno-arterial (VA) ECMO for ACS between January 2015 and June 2020. These patients were divided into survivors and non-survivors based on 6-month survival. All clinical data before and during ECMO were compared between the 2 groups. Results: Patients' mean age was 66.0±10.5 years, and 116 (78.4%) were men. The total survival rate was 45.9% (n=68). Cox regression analysis showed that the pre-ECMO lactate level was an independent predictor of 6-month mortality (hazard ratio, 1.210; 95% confidence interval [CI], 1.064-1.376; p=0.004). The area under the receiver operating characteristic curve of pre-ECMO lactate was 0.64 (95% CI, 0.56-0.72; p=0.002; cut-off value=9.8 mmol/L). Kaplan-Meier survival analysis showed that the cumulative survival rate at 6 months was significantly higher among patients with a pre-ECMO lactate level of 9.8 mmol/L or less than among those with a level exceeding 9.8 mmol/L (57.3% vs. 31.8%, p=0.0008). Conclusion: A pre-ECMO lactate of 9.8 mmol/L or less may predict a favorable outcome at 6 months in ACS patients undergoing VA-ECMO. Further research aiming to improve the accuracy of predictions of reversibility in patients with high pre-ECMO lactate levels is essential.

• Korean Chemical Engineering Research
• /
• 제47권6호
• /
• pp.740-746
• /
• 2009

본 논문에서는 L(+)-calcium lactate를 정밀 분리하기 위한 drowning-out 결정화 기술에 대해 연구하였다. Calcium lactate 결정화는 calcium lactate 수용액에 반용매를 투입하여 유도하였으며 결정화 공정에서 결정입자의 크기를 제어할 수 있는 기술을 연구하였다. 결정화 공정에서 결정입자에 영향을 주는 인자로서 반용매의 종류, 반용매의 조성 그리고 교반속도를 고려하였다. 반용매로서는 알콜류(메탄올, 에탄올, n-프로판올, i-프로판올)를 선택하였다. 결정화 실험에 앞서, 과포화도를 고려하기 위하여 물-알콜 혼합용액에서의 calcium lactate의 용해도를 측정하였다. Drowning-out 결정화에 의해 fabric 모양의 calcium lactate 결정이 석출되었는데, 에탄올의 경우 fabric이 굵고 침상에 가까운 모양이었으며, 프로판올의 경우 hairy 모양에 가까웠다. 이러한 형상 특징으로 인하여 결정이 강하게 응집하는 경향을 보였다. 응집경향은 수용액에 대한 알콜 조성이 증가할수록 증가하였다. 반면 교반은 응집된 결정입자를 파쇄하는 효과가 강하게 나타났다. 따라서 결정화를 통해 얻어지는 결정입자의 크기는 반용매에 의한 결정입자 응집과 교반에 의한 결정입자 파쇄의 상대적 강도에 의존하였다.

• Journal of Yeungnam Medical Science
• /
• 제12권1호
• /
• pp.48-55
• /
• 1995

1995년 1월에서 1995년 3월까지 심근 손상이 의심되는 환자 및 정상대조군에 대한 TnT, 총 LD, 총 CK 및 각 동위효소에 대한 고찰에서 다음과 같은 결과를 얻었다. Tropohin T는 정상인에서 $0.01{\pm}0.02{\mu}g/L$, 급성심근경색환자에서 최고치는 4.7-24.2 ${\mu}g/L$로 나타났으며, 초기검사에서 정상범위에 속한 환자에서 6시간 후 추적조사에서는 모든 증례에서 1.0 ${\mu}g/L$이상으로 나타났다. 총 LD는 1-3일경에 최고치를 보인 후 점차적으로 감소되었으나, LD1/LD2 비율은 대부분의 환자에서 10일 이상 1.0이상으로 유지되므로, 상대적으로 늦은 시간에 내원한 경우 총 LD와 LD1/LD2 비율이 진단에 유용할 것으로 사료되었다. 총 CK 및 CK-MB인 경우 대부분의 환자에서 3-4일 후 정상 범위로 떨어지므로, 조기진단에는 도움이 되나, 장기간의 추적조사에는 유용성이 없는 것으로 사료되었다. 총 Lactate Dehydrogenase, LD1/LD2 비율, 총 Creatine Kinase, CK-MB와 Troponin T의 상호비교에서 Troponin T가 상대적으로 초기 혹은 장기간 경과된 경우에도 유용한 지표로 사료되었다.

• Neonatal Medicine
• /
• 제17권2호
• /
• pp.254-261
• /
• 2010

신생아에서의 미토콘드리아 질환은 임상 증상이 다양하고 비특이적이라 진단이 어렵고, 치명적으로 생존율이 낮기 때문에 이에 대한 연구는 미비하다. 본 연구에서는 신생아기에 미토콘드리아 질환 소견으로 치료한 3례를 보고하였다. 증례 1은 갑작스럽게 발생한 강직성 경련, 의식 소실 및 심한 대사성 산증과다기관 기능 부전으로 미토콘드리아 병증이 의심되었다. 혈장내 젖산/피루브산염 비가 55.6, 아미노산 검사에서는 알라닌 2,237 nmol/ml로 증가되었다. 증례 2에서는 급성 부신기능부전과 급성 신부전으로 복막 투석을 하였으나 대사성 산증이 지속되었다. 혈장 내 젖산/피루브산염 비가 23.9였고, 근 조직을 이용한 효소 분석에서 1번 복합체의 호흡 사슬 결함이 진단되었다. 증례 3은 출생 후 2개월간 반복되는 대사성 산증과 기면, 수유 곤란 소견을 보였다. 혈장 내 젖산/피루브산염 비가 19.4로 정상 범위의 경계에 있었으나 뇌척수액 검사상 젖산/피루브산염 비가 57로 현저하게 증가된 소견을 보였고, 뇌 자기 공명 분광경 검사에서 lactate peak 소견을 보였다. 근 조직을 이용한 효소 분석에서 2번 복합체의 호흡 사슬 결함이 진단되었다. 세증례 모두에서 미토콘드리아 질환 소견으로 비타민, 조효소 Q10 및 L-카르니틴을 투여하였다.

• 대한임상독성학회지
• /
• 제14권1호
• /
• pp.16-25
• /
• 2016

Purpose: Patients suffering from acute poisoning by different substances often visit the emergency department (ED) and receive various prognoses according to the toxic material and patients' condition. Hyperlactatemia, which is an increased blood lactate level that generally indicates tissue hypoperfusion, is commonly utilized as a prognostic marker in critically ill patients such as those with sepsis. This study was conducted to investigate the relationships between blood lactate and clinical prognosis in acute poisoned patients. Methods: This retrospective study was conducted from January 2013 to June 2014 at a single and regional-tertiary ED. We enrolled study patients who were examined for blood test with lactate among acute intoxicated patients. The toxic materials, patient demographics, laboratory data, and mortalities were also reviewed. Additionally, we analyzed variables including blood lactate to verify the correlation with patient mortality. Results: A total of 531 patients were enrolled, including 24 (4.5%) non-survivors. Patient age, Glasgow coma scale (GCS), serum creatinine (Cr), aspartate transaminase (AST), and serum lactate differed significantly between survivors and non-survivors in the binary logistic regression analysis. Among these variables, GCS, AST, and lactate differed significantly. The median serum lactate levels were 2.0 mmol/L among survivors and 6.9 mmol/L among non-survivors. The AUC with the ROC curve and odds ratio of the initial serum lactate were 0.881 and 3.06 (0.89-8.64), respectively. Conclusion: Serum lactate was correlated with fatalities of acute poisoning patients in the ED; therefore, it may be used as a clinical predictor to anticipate their prognoses.

• 대한수의학회지
• /
• 제39권6호
• /
• pp.1081-1090
• /
• 1999

To establish the protocol of a standardized exercise test for evaluating exercise intolerance and degree of fitness in Thoroughbred racehorses, we examined serum lactate concentrations related to exercise intensities using the high speed treadmill. Twelve clinically healthy Thoroughbred racehorses with or without previous training or racing history were assigned to two gorups, fit and unfit group, respectively. The protocol used for the standardized exercise test was consisted of two stages : stage of warm-up and that of acceleration. During the warm-up, the horses exercised 5 min at 1.8m/s and 3 min 3.4m/s without inclination. At the acceleration stage, exercise test was performed at 10% slope and the speed was increased from the initial 5m/s to the maximal speed which each tested horse could keep up with. The speed was increased with incremental steps of 1 m/s every minute. During the last 15 sec of each step, blood samples were collected for serum lactate determination. $V_{max}$(maximal treadmill speed which tested horses could keep up with) of the fit group ($10.93{\pm}0.33m/s$, mean${\pm}$SE, n = 6) was higher than that of the unfit group ($9.52{\pm}0.23m/s$, mean${\pm}$SE, n = 6). Serum lactate concentrations increased exponentially according to exercise intensities. $V_{La4}$(speed producing a serum lactate concentration of 4mmol/l) of the fit group, $6.45{\pm}0.26m/s$, was higher than that of the unfit group, $5.45{\pm}0.23m/s$. $La_{peak}$(peak plasma lactate concentration during the exercise test) was lower in the fit group ($20.34{\pm}1.62mmol/l$ at 1 min after maximal intensity exercise) than in the unfit group ($24.78{\pm}1.09mmol/l$ at 2 min after maximal exercise step). $t_{50%}$(time required for the recovery of lactate concentration to be one-half of $La_{peak}$ after maximal exercise) of the unfit group and the fit group were 40.0 and 18.0 min, respectively. Therefore, the protocol of the incremental standardized exercise test utilized in this study seems to be reliable for the assessment of fitness and exercise intolerance for the Thoroughbred racehorses.

• BMB Reports
• /
• 제32권2호
• /
• pp.140-146
• /
• 1999

When murine fibrosarcoma L929 cells, a TNF-sensitive cell line, were treated with recombinant human tumor necrosis factor-$\alpha$ (rhTNF-$\alpha$), the activities of glycolytic regulatory enzymes and lactate dehydrogenase increased up to 100-150% compared to the control L929 cells after TNF treatment. By using various metabolic inhibitors and activators, it was found that cAMP-dependent protein kinase is responsible for the increase of activities of the glycolytic enzymes. The activities of glycolytic regulatory enzymes and lactate dehydrogenase of TNF-resistant A549 cells, a human lung carcinoma cell line, did not increase significantly compared to TNF-sensitive L929 cells upon TNF treatment. In contrast, the pyruvate carboxylase activities of A549 cells, but not L929 cells, increased up to 30~40% after TNF treatment. The data suggest that pyruvate carboxylase activity may contribute to the compensation of energy loss mediated by TNF treatment in TNF-resistant A549 cells.